Marker Tables: B-lymphoproliferative disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| (8 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
'''Notes:''':</span> | '''Notes:''':</span> | ||
*<span style="color:black;font-size:90% ">Click the disorder name (top row of table) further details</span> | *<span style="color:black;font-size:90% ">Click the disorder name (top or section row of table) further details</span> | ||
*<span style="color:black;font-size:90% ">Click the marker name (left column) for full description</span> | *<span style="color:black;font-size:90% ">Click the marker name (left or right column) for full description</span> | ||
*<span style="color:black;font-size:90% ">Mobile phone users: scroll table left to right or view landscape</span> | *<span style="color:black;font-size:90% ">Mobile phone users: scroll table left to right or view landscape</span> | ||
---- | ---- | ||
| Line 46: | Line 46: | ||
|colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Follicular Lymphoma|'''FL<span style="color:white>XXX''']] | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Follicular Lymphoma|'''FL<span style="color:white>XXX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Diffuse Large B-cell Lymphoma|'''DLBCL''']] | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Diffuse Large B-cell Lymphoma|'''DLBCL''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Marginal Zone Lymphoma|'''MZL''']] | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Marginal Zone Lymphoma|'''MZL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Hairy Cell Leukaemia|'''HCL''']] | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Hairy Cell Leukaemia|'''HCL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Lymphoplasmacytic Lymphoma| | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Lymphoplasmacytic Lymphoma|LPL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Plasma cells| | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Plasma cells|PC<span style="color:white>XXX''']] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |[[Immunoglobulin light chains|κ/λ]] | |colspan="1" style = "font-size:90%; color:black;" |[[Immunoglobulin light chains|κ/λ]] | ||
| Line 60: | Line 60: | ||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|'''var''' | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|'''var''' | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "font-size:90%; color:black;" |κ/λ | |colspan="1" style = "font-size:90%; color:black;" |[[Immunoglobulin light chains|κ/λ]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |[[CD19]] | |colspan="1" style = "font-size:90%; color:black;" |[[CD19]] | ||
| Line 71: | Line 71: | ||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | ||
|colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | |colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | ||
|colspan="1" style = "font-size:90%; color:black;" |CD19 | |colspan="1" style = "font-size:90%; color:black;" |[[CD19]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |[[CD20]] | |colspan="1" style = "font-size:90%;" |[[CD20]] | ||
| Line 82: | Line 82: | ||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | ||
|colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | |colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | ||
|colspan="1" style = "font-size:90%;" |CD20 | |colspan="1" style = "font-size:90%;" |[[CD20]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |[[CD79b]] | |colspan="1" style = "font-size:90%; color:black;" |[[CD79b]] | ||
| Line 93: | Line 93: | ||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | ||
|colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | |colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | ||
|colspan="1" style = "font-size:90%; color:black;" |CD79b | |colspan="1" style = "font-size:90%; color:black;" |[[CD79b]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |[[FMC7]] | |colspan="1" style = "font-size:90%; color:black;" |[[FMC7]] | ||
| Line 104: | Line 104: | ||
|colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"| | |colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"| | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "font-size:90%; color:black;" |FMC7 | |colspan="1" style = "font-size:90%; color:black;" |[[FMC7]] | ||
|- | |- | ||
!colspan="10" style = "font-size:100%; color: black; text-align:left; background:pale gray;"|Marker that help distinguish B-LPD type (CLL, MCL) | !colspan="10" style = "font-size:100%; color: black; text-align:left; background:pale gray;"|Marker that help distinguish B-LPD type (CLL, MCL) | ||
|- | |- | ||
|colspan="1" style = "font-size:80%; width: 15%; | | |colspan="1" style = "font-size:80%; width: 15%; | | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''CLL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Chronic Lymphocytic leukaemia|'''CLL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''MCL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Mantle Cell Lymphoma|'''MCL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''FL<span style="color:white>XXX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Follicular Lymphoma|'''FL<span style="color:white>XXX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''DLBCL''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Diffuse Large B-cell Lymphoma|'''DLBCL''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''MZL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Marginal Zone Lymphoma|'''MZL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''HCL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Hairy Cell Leukaemia|'''HCL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; | | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Lymphoplasmacytic Lymphoma|LPL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; | | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Plasma cells|PC<span style="color:white>XXX''']] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |[[CD5]] | |colspan="1" style = "font-size:90%;" |[[CD5]] | ||
| Line 127: | Line 127: | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "font-size:90%;" |CD5 | |colspan="1" style = "font-size:90%;" |[[CD5]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |[[CD23]] | |colspan="1" style = "font-size:90%; color:black;" |[[CD23]] | ||
| Line 138: | Line 138: | ||
|colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | |colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "font-size:90%; color:black;" |CD23 | |colspan="1" style = "font-size:90%; color:black;" |[[CD23]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |[[CD200]] | |colspan="1" style = "font-size:90%; color:black;" |[[CD200]] | ||
| Line 149: | Line 149: | ||
|colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | |colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | ||
|colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"| | |colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"| | ||
|colspan="1" style = "font-size:90%; color:black;" |CD200 | |colspan="1" style = "font-size:90%; color:black;" |[[CD200]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |[[CD43]] | |colspan="1" style = "font-size:90%;" |[[CD43]] | ||
| Line 160: | Line 160: | ||
|colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"|'''var''' | |colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"|'''var''' | ||
|colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"|'''var''' | |colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"|'''var''' | ||
|colspan="1" style = "font-size:90%;" |CD43 | |colspan="1" style = "font-size:90%;" |[[CD43]] | ||
|- | |- | ||
!colspan="10" style = "font-size:100%; color: black; text-align:left; background:pale gray;"|Markers that help distinguish B-LPD type (FL, DLBCL) | !colspan="10" style = "font-size:100%; color: black; text-align:left; background:pale gray;"|Markers that help distinguish B-LPD type (FL, DLBCL) | ||
|- | |- | ||
|colspan="1" style = "font-size:80%; width: 15%; | | |colspan="1" style = "font-size:80%; width: 15%; | | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''CLL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Chronic Lymphocytic leukaemia|'''CLL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''MCL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Mantle Cell Lymphoma|'''MCL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''FL<span style="color:white>XXX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Follicular Lymphoma|'''FL<span style="color:white>XXX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''DLBCL''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Diffuse Large B-cell Lymphoma|'''DLBCL''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''MZL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Marginal Zone Lymphoma|'''MZL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''HCL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Hairy Cell Leukaemia|'''HCL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; | | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Lymphoplasmacytic Lymphoma|LPL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; | | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Plasma cells|PC<span style="color:white>XXX''']] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |[[CD10]] | |colspan="1" style = "font-size:90%;" |[[CD10]] | ||
| Line 183: | Line 183: | ||
|colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | |colspan="1" style = "background:#66e0ff;color:black;font-size:80%""| | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "font-size:90%;" |CD10 | |colspan="1" style = "font-size:90%;" |[[CD10]] | ||
|- | |- | ||
!colspan="10" style = "font-size:100%; color: black; text-align:left; background:pale gray;"|Markers that help distinguish B-LPD type (MZL, HCL) | !colspan="10" style = "font-size:100%; color: black; text-align:left; background:pale gray;"|Markers that help distinguish B-LPD type (MZL, HCL) | ||
|- | |- | ||
|colspan="1" style = "font-size:80%; width: 15%; | | |colspan="1" style = "font-size:80%; width: 15%; | | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''CLL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Chronic Lymphocytic leukaemia|'''CLL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''MCL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Mantle Cell Lymphoma|'''MCL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''FL<span style="color:white>XXX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Follicular Lymphoma|'''FL<span style="color:white>XXX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''DLBCL''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Diffuse Large B-cell Lymphoma|'''DLBCL''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''MZL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Marginal Zone Lymphoma|'''MZL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''HCL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Hairy Cell Leukaemia|'''HCL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; | | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Lymphoplasmacytic Lymphoma|LPL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; | | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Plasma cells|PC<span style="color:white>XXX''']] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |[[CD11c]] | |colspan="1" style = "font-size:90%;" |[[CD11c]] | ||
| Line 206: | Line 206: | ||
|colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"| | |colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"| | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "font-size:90%;" |CD11c | |colspan="1" style = "font-size:90%;" |[[CD11c]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |[[CD25]] | |colspan="1" style = "font-size:90%; color:black;" |[[CD25]] | ||
| Line 217: | Line 217: | ||
|colspan="1" style = "background:#00b8e6;color:black; font-size:80%"| | |colspan="1" style = "background:#00b8e6;color:black; font-size:80%"| | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "font-size:90%; color:black;" |CD25 | |colspan="1" style = "font-size:90%; color:black;" |[[CD25]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |[[CD103]] | |colspan="1" style = "font-size:90%;" |[[CD103]] | ||
| Line 228: | Line 228: | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"| | ||
|colspan="1" style = "font-size:90%;" |CD103 | |colspan="1" style = "font-size:90%;" |[[CD103]] | ||
|- | |- | ||
!colspan="10" style = "font-size:100%; color: black; text-align:left; background:pale gray;"|Markers that help distinguish B-LPD type (LPL, PC) | !colspan="10" style = "font-size:100%; color: black; text-align:left; background:pale gray;"|Markers that help distinguish B-LPD type (LPL, PC) | ||
|- | |- | ||
|colspan="1" style = "font-size:80%; width: 15%; | | |colspan="1" style = "font-size:80%; width: 15%; | | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''CLL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Chronic Lymphocytic leukaemia|'''CLL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''MCL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Mantle Cell Lymphoma|'''MCL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''FL<span style="color:white>XXX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Follicular Lymphoma|'''FL<span style="color:white>XXX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''DLBCL''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Diffuse Large B-cell Lymphoma|'''DLBCL''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''MZL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Marginal Zone Lymphoma|'''MZL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; |'''HCL<span style="color:white>XX''' | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Hairy Cell Leukaemia|'''HCL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; | | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Lymphoplasmacytic Lymphoma|LPL<span style="color:white>XX''']] | ||
|colspan="1" style = "font-size:80%; width: 10%; | | |colspan="1" style = "font-size:80%; width: 10%; |[[Flow cytometry: Plasma cells|PC<span style="color:white>XXX''']] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |[[CD38]] | |colspan="1" style = "font-size:90%; color:black;" |[[CD38]] | ||
| Line 251: | Line 251: | ||
|colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"| | |colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"| | ||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | ||
|colspan="1" style = "font-size:90%; color:black;" |CD38 | |colspan="1" style = "font-size:90%; color:black;" |[[CD38]] | ||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |[[CD138]] | |colspan="1" style = "font-size:90%;" |[[CD138]] | ||
| Line 262: | Line 262: | ||
|colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"|var | |colspan="1" style = "width: 8%; background:#006699;color:white;font-size:80%"|var | ||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"| | ||
|colspan="1" style = "font-size:90%;" |CD138 | |colspan="1" style = "font-size:90%;" |[[CD138]] | ||
|- | |- | ||
|} | |} | ||
Latest revision as of 18:24, 14 July 2023
Notes::
- Click the disorder name (top or section row of table) further details
- Click the marker name (left or right column) for full description
- Mobile phone users: scroll table left to right or view landscape
| COLOUR KEY | <5% | 5-20 | 20:40 | 40:80 | >80 | |||
| Colours are graded and indicate the likelihood of any individual case expressing the indicated marker | ||||||||
|---|---|---|---|---|---|---|---|---|
| Immunophenotype B-LPD | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Lineage and general markers | |||||||||
| CLLXX | MCLXX | FLXXX | DLBCL | MZLXX | HCLXX | LPLXX | PCXXX | ||
| κ/λ | wk | var | var | stg | var | κ/λ | |||
| CD19 | wk | CD19 | |||||||
| CD20 | wk | stg | CD20 | ||||||
| CD79b | wk | CD79b | |||||||
| FMC7 | wk | wk | var | stg | FMC7 | ||||
| Marker that help distinguish B-LPD type (CLL, MCL) | |||||||||
| CLLXX | MCLXX | FLXXX | DLBCL | MZLXX | HCLXX | LPLXX | PCXXX | ||
| CD5 | stg | CD5 | |||||||
| CD23 | CD23 | ||||||||
| CD200 | CD200 | ||||||||
| CD43 | var | var | var | CD43 | |||||
| Markers that help distinguish B-LPD type (FL, DLBCL) | |||||||||
| CLLXX | MCLXX | FLXXX | DLBCL | MZLXX | HCLXX | LPLXX | PCXXX | ||
| CD10 | stg | CD10 | |||||||
| Markers that help distinguish B-LPD type (MZL, HCL) | |||||||||
| CLLXX | MCLXX | FLXXX | DLBCL | MZLXX | HCLXX | LPLXX | PCXXX | ||
| CD11c | wk | wk | stg | CD11c | |||||
| CD25 | wk | wk | wk | CD25 | |||||
| CD103 | CD103 | ||||||||
| Markers that help distinguish B-LPD type (LPL, PC) | |||||||||
| CLLXX | MCLXX | FLXXX | DLBCL | MZLXX | HCLXX | LPLXX | PCXXX | ||
| CD38 | CD38 | ||||||||
| CD138 | var | CD138 | |||||||